Skip to main content

Treatment Duration on OLYSIO® | HCP

Treatment Duration on OLYSIO® | HCP

No treatment-stopping rules apply to the combination of OLYSIO® with SOF.

Patients with HCV GT1a and Q80K polymorphism

Prior to initiation of treatment with OLYSIO® + SOF, screening patients infected with
HCV GT1a for the presence of virus with the NS3 Q80K polymorphism is not strongly
recommended but may be considered